News on Hematology continually updated from thousands of sources around the net.
Trending on the Topix Network
Onconova Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today provided a corporate update and reported financial results for its year ended December 31, 2013.
St. Luke's University Health Network is one of three sites nationwide chosen to enroll patients in a new study using the therapeutic agent PV-10 for late-stage liver cancer.
FILE PIC: Ballarat Oncology and Haematology Services Clinical Trials Unit principal investigator Professor George Kannourakis is seeking participants for a lung cancer research trial.
Research physicians at UCLA's Jonsson Comprehensive Cancer Center have begun a clinical trial on a new device that promises to reduce hair loss of patients receiving chemotherapy for breast cancer .
Novartis Drug PrJakaviA Associated with Significant Clinical Benefit for Patients with Debilitating and Life-threatening Blood Cancer Myelofibrosis DORVAL, QC , March 7, 2014 /CNW/ - Study results presented at the 55th American Society of Hematology annual meeting showed that patients with myelofibrosis who received treatment with JakaviA sustained ... (more)
Roche announced today that William Pao, M.D., Ph.D., Professor of Medicine and Head of the Hematology-Oncology Division at Vanderbilt University Medical Center in the US, will join Roche Pharma Research and Early Development as Global Head of the Oncology Disease and Translational Area , effective 1 May 2014.
One of the world's leading experts in the treatment of blood disorders has warned of an "intrinsic ageism" within the medical profession, preventing many elderly patients from receiving beneficial cancer treatment.
Lung cancer is the only one of the four deadliest cancers in the United States that is not subject to routine screenings.
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire 1Centre Hospitalier et Universitaire de Nantes, Hématologie Clinique, Centre d’Investigation Clinique en ... (more)
Multiple myeloma is cancer of the bone marrow, an incurable type of the disease that kills about 10,700 people a year.
Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia Correspondence: Professor M Scherr or Professor M Eder, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Carl-Neuberg Strasse 1, Hannover 30623, Germany.
It carries out research, develops and distributes pharmaceutical products. The company operates in four business divisions which include therapeutics, hospital, juste consumer health and international division.
Correspondence: Dr M Murata, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466-8550, Japan.